LIVER GALLBLADDER CLEANSE | MULTIPLE CHEMICAL SENSITIVITIES
CANDIDA FUNGUS TREATMENT| PROSTATE NATURAL REMEDY
HEAVY METAL DETOXIFICATION| HYPERBARIC CHAMBERS
http://www.balancedhealthtoday.com/endosterol.html
Given that the median age of death from prostate cancer is 80 years, the US Preventive Service Task Force has recently concluded that available evidence is insufficient to assess the balance between potential benefits and harms of using the Prostate Specific Antigen (PSA) to screen men 75 years old for prostate cancer and has recommended against screening men 75 years old. Not all professional organizations agree with these conclusions and heated debates continue even though, in a 12-year study, treating localized prostate cancers in men 65 years old showed no benefit over watchful waiting.
In autopsy studies, prostate cancer has been reported to occur in 15-60% of men 60 years old. In one autopsy study of men (median age 64 years) who had died of other causes with no evidence of prostate cancer, careful tissue sections detected cancer in 29%. Such a high frequency of undetected prostate cancers in older men suggests that most of these cancers tend to be of the innocent type.
Although Prostate Specific Antigen (PSA) screening has been associated with a decrease in prostate cancer death rates, detection of clinically unimportant cancers continues to be a problem. Given that over diagnosis leads to over treatment, men need to know that Prostate Specific Antigen screening, which might lead to unnecessary anxiety and unnecessary procedures, might also be life saving. Because of these dichotomies, individualizing screening and treatment is the wiser way.
Finland, Helsinki
Zambia, Lusaka
Cape Verde, Praia
Lichtenstein, Vaduz
San Jose, California
Kansas City, Missouri
Cleveland Ohio USA
Grand Rapids, Michigan
The Netherlands, Amsterdam
Abu Dhabi, United Arab Emirates, Abu Dhabi, UAE